Skip to content
MedsAcross

Medicine

Triamcinolone acetonide 50 mg/5 mL injectable suspension

Triamcinolone acetonide · Intra-articular, intralesional
Available on requestPrescription onlyUS FDAGeneric name

Triamcinolone acetonide 50 mg/5 mL injectable suspension is a generic prescription medicine for intra-articular, intralesional use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Do not refrigerate. Store at controlled room temperature, 20°C to 25°C (68°F…

Key facts

Active ingredient (INN)
Triamcinolone acetonide
Brand
Sold under the generic name
Strength
50 mg/5 mL
Dosage form
Injectable suspension
Route
Intra-articular, intralesional
Packs
1 vial of 5 mL
Manufacturer
Dr. Reddy's LaboratoriesIndia
Origin register
US FDA, United States
Storage
Do not refrigerate. Store at controlled room temperature, 20°C to 25°C (68°F to 77°F), protect from temperatures below 20°C (68°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F). Once in use: Chemical and physical in-use stability has been demonstrated for 28 days at 20°C to 25°C (68°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
4 August 2025
Identifiers
RxCUI 1085750DailyMed set ID 8190195b-9847-d3d5-76a4-015cc24307e5NDC 43598-676Application ANDA218773

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose43598-676-11Dr. Reddy's LaboratoriesIndia4 August 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 23 October 1958Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Triamcinolone acetonide 50 mg/5 mL injectable suspension.

Compare 1

Other strengths and forms of Triamcinolone acetonide

Clinical summary

Triamcinolone acetonide is a corticosteroid indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis. MedsAcross supplies Triamcinolone acetonide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Triamcinolone acetonide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Triamcinolone acetonide 50 mg/5 mL injectable suspension for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.